Whether , Comora or Baldwyx turn out to be correct , either way it’s a long way up from the $5 peak that most here had pegged out a few years ago.
It all depends if we get an auction going. Having another 5 animal studies done and maybe 5 phase 2’ s done would certainly push the valuation a long way north of our current price.
A pipeline like that woukd show NNZ2591 has all the potential to be a winner in the market just like Keytruda was. That woukd land us a super premium!
Ann: 2023 Annual Report to shareholders, page-70
-
- There are more pages in this discussion • 125 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.56 |
Change
-0.360(2.59%) |
Mkt cap ! $1.733B | |||
| Open | High | Low | Value | Volume |
| $13.94 | $13.96 | $13.50 | $6.421M | 470.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1643 | $13.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.61 | 3100 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |